Search results

Einar Smith is being awarded the Swedish Savings Bank Foundation scholarship for his thesis. A prospective study which demonstrates that the metabolite ergothioneine, independent of other risk factors, can be linked to a reduced risk of cardiovascular disease and premature death. The study is published in BMJ Heart. Einar Smith is being awarded the Swedish Savings Bank Foundation scholarship for b

https://www.medicine.lu.se/article/connection-between-markers-healthy-diet-and-reduced-risk-cardiovascular-disease-resulted-scholarship - 2025-10-15

Para-athletics is growing in strength worldwide. However, behind the Paralympics that we watch on TV from our sofas there are greater challenges than those related to results. A new thesis from Lund University demonstrates how Paralympic athletes run the risk of sustaining injuries as a result of strict training as well as illnesses caused by their disability. To ensure that the athletes stay heal

https://www.medicine.lu.se/article/paralympic-athletes-double-struggle-against-injuries-and-diseases - 2025-10-15

The European Research Council today announced the winners of its latest Consolidator Grant competition: 301 top scientists and scholars across Europe. Funding for these researchers, part of the Horizon 2020 research and innovation programme, is worth in total EUR 600 million. Filipe Pereira at Lund University in Sweden is one of the 89 selected researchers, and will be awarded an ERC Consolidator

https://www.medicine.lu.se/article/prestigious-erc-grant-innovative-immunotherapy-research - 2025-10-15

Zaal Kokaia, Professor within the Department of Clinical Sciences and Director of Lund Stem Cell Center, has been awarded Georgia’s most prestigious scientific prize - the National Prize in Science. The award comes as a result of his outstanding contribution to world class scientific research and was presented to Prof. Kokaia at a ceremony in the Presidential Palace, Tbilisi, by the Georgian Presi

https://www.medicine.lu.se/article/prestigious-scientific-prize-awarded-director-lund-stem-cell-center - 2025-10-15

A few weeks ago The Huntington Disease Center in Lund, Sweden, welcomed researchers, clinicians and representatives from patient organizations in the Nordic countries to the second Nordic Huntington Disease Research Meeting in Lund. Among the prominent visitors were Patrick Weydt, representative of the European Huntington Disease Network and Astri Arnesen, President of The European Huntington Asso

https://www.medicine.lu.se/article/european-huntington-heights-met-lund-summit - 2025-10-15

The risk of experiencing financial difficulties due to medical care costs is relatively small in Sweden. This is revealed in a recent report from the World Health Organization, where researchers from Lund University have investigated the extent to which Swedish households are financially affected by using the health care system. “The Swedish health care system protects residents from catastrophic

https://www.medicine.lu.se/article/who-report-healthcare-sweden-among-most-affordable-europe - 2025-10-15

Researchers at Lund University in Sweden have used a neuropeptide to successfully reduce seizure-like activity in tissue from patients with drug-resistant epilepsy. One challenge facing researchers who study brain diseases is that for understandable reasons it is difficult to obtain human brain tissue for experiments. For that reason, experimental models are used, such as rodent studies, but one p

https://www.medicine.lu.se/article/peptide-reduced-epileptic-seizures-human-brain-tissue - 2025-10-15

Researchers at Lund University in Sweden have developed a new hydrogel based on the body’s natural peptide defense. It has been shown to prevent and treat infections in wounds. The formulation kills multi-resistant bacteria, something that is increasing in importance with antibiotic resistance growing globally. “The ability to effectively heal wounds is key for our survival in evolutionary terms.

https://www.medicine.lu.se/article/next-generation-wound-gel-treats-and-prevents-infections - 2025-10-15

European complementologists have joined forces and created CORVOS. A highly coordinated and innovative research and training program for early stage researchers in immunology and infectious diseases. Lund University is a part of the initiative. The major aims of CORVOS are the discovery of therapeutic ways to support or inhibit the action of complement and to interfere with its abuse by pathogens

https://www.medicine.lu.se/article/corvos-european-joint-doctorate-programme-immunology - 2025-10-15

Cancer patients responded better to immunotherapy and had a better prognosis if their melanoma tumours contained specific clusters of B cells, according to new research from Lund University in Sweden. The study is published in Nature. Immunotherapy strengthens the immune system so that it can fight cancer more effectively. One type of immunotherapy is checkpoint therapy, that targets the checkpoin

https://www.medicine.lu.se/article/b-cells-linked-effective-cancer-immunotherapy - 2025-10-15

In a major study of hereditary breast cancer, a global network of researchers (including some from Lund University) has identified over 350 faults in DNA that increase an individual’s risk of developing the disease. The researchers believe that these faults can affect as many as 190 genes. Published in Nature Genetics, a scientific journal, the results are said to be the thus far most comprehensiv

https://www.medicine.lu.se/article/major-study-gives-most-comprehensive-map-breast-cancer-risk - 2025-10-15

Up to 45 per cent of all deaths in industrialised countries are caused by fibrotic diseases. Through boundary-crossing research and the high-tech MAX IV laboratory in Lund it is possible to increase the knowledge of fibrosis – bringing a cure closer. ”Fibrosis is a form of scarring that can affect all types of damaged organs and tissues in the body. When this process takes place in an out of contr

https://www.medicine.lu.se/article/high-tech-collaboration-supports-fibrosis-research - 2025-10-15

Within the framework of an international study, Lund University and Skåne University Hospital have started treating patients with hemophilia with gene therapy, something that began in January this year. The hope is that the new treatment will significantly simplify everyday life for those with severe hemophilia. Hemophilia is a genetic disease where the body does not produce one of the clotting fa

https://www.medicine.lu.se/article/hemophilia-being-treated-gene-therapy - 2025-10-15

The Leif C. Groop Award for Outstanding Diabetes Research has been awarded to Niels Grarup of the Novo Nordisk Foundation Centre for Basic Metabolic Research at the University of Copenhagen. His research has shown that there is a genetic explanation for the increase in type 2 diabetes in Greenland. The prize, worth SEK 100 000, is donated by the pharmaceutical company Novo Nordisk Scandinavia. Nie

https://www.medicine.lu.se/article/award-research-increased-risk-type-2-diabetes-greenland - 2025-10-15

In their quest to find new and better methods to make cancer cells more susceptible to treatment, Karin Lindkvist and her research group at Lund University in Sweden are looking into the world of molecules, using the X-rays at the MAX IV laboratory. The researchers believe that limiting the cells' access to sugar will make cancer cells more sensitive to treatment. Many of the cancer treatments use

https://www.medicine.lu.se/article/researchers-believe-sugar-and-obesity-can-make-cancer-cells-more-difficult-kill - 2025-10-15

The more sugar we eat, the less vitamins and minerals we consume, new findings from Lund University in Sweden show. However, the researchers behind the study do not believe that their results alone are enough to make changes to current dietary recommendations. High sugar intake has been associated with numerous diseases and conditions such as poor dental health, obesity, diabetes, and cardiovascul

https://www.medicine.lu.se/article/more-sugar-less-vitamins-we-eat-study-shows - 2025-10-15

A new epidemiological study from Lund University and Skåne University Hospital in Sweden shows that there is a connection between high levels of the gastrointestinal hormone GIP in the blood, and an elevated risk of cardiovascular disease. It is well known that the intestinal hormones GIP and GLP-1 are important for insulin production in the pancreas. They form in the intestines as we eat, and reg

https://www.medicine.lu.se/article/gut-hormone-can-increase-risk-cardiovascular-disease - 2025-10-15

Diabetes, cardiovascular disease, Parkinson's and Alzheimer's disease make up the world’s most common diseases. A new biobank at Lund University in Sweden - the largest of its kind - with stem cells from both those affected and healthy individuals, will contribute to an increased understanding of how these diseases arise. “The goal is for researchers to be able to develop new treatments that can p

https://www.medicine.lu.se/article/worlds-largest-stem-cell-biobank-launched - 2025-10-15

As the body ages, there is a general loss of function in all organs. Among other things this leads to declining renal function and osteoporosis among the elderly, the latter to a greater extent among women. A new doctoral dissertation from Lund University illuminates women’s aging and investigates the relationship between two common age-related diseases – kidney failure and osteoporosis. The kidne

https://www.medicine.lu.se/article/kidney-function-and-osteoporosis-elderly - 2025-10-15

How accessible are Swedish homes to the elderly? Pensioners, teachers and students all over Sweden will be helping researchers at the Centre for Ageing and Supportive Environments (CASE) at Lund University to find out in the ForskarFredag (Researchers’ Friday) 2020 mass experiment – the Housing Experiment. Professor Susanne Iwarsson, coordinator for CASE and head of the Active and Healthy Ageing R

https://www.medicine.lu.se/article/out-tape-measure-first-time-sweden-mass-experiment-involving-elderly - 2025-10-15